Emerald Mutual Fund Advisers Trust Ani Pharmaceuticals Inc Transaction History

Emerald Mutual Fund Advisers Trust

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$37.29 - $53.83 $6 Million - $8.67 Million	-161,001 Reduced 52.57%	145,276 $7.82 Million
Q1 2023 May 04, 2023	SELL	$37.61 - $45.72 $955,820 - $1.16 Million	-25,414 Reduced 7.66%	306,277 $12.2 Million
Q4 2022 Feb 03, 2023	SELL	$31.9 - $41.95 $213,953 - $281,358	-6,707 Reduced 1.98%	331,691 $13.3 Million
Q3 2022 Oct 25, 2022	SELL	$29.83 - $38.01 $550,870 - $701,930	-18,467 Reduced 5.17%	338,398 $10.9 Million
Q2 2022 Jul 29, 2022	BUY	$23.09 - $33.46 $1.32 Million - $1.92 Million	57,372 Added 19.16%	356,865 $10.6 Million
Q1 2022 Apr 29, 2022	BUY	$26.91 - $47.15 $5.65 Million - $9.9 Million	210,002 Added 234.66%	299,493 $8.42 Million
Q4 2021 Feb 02, 2022	BUY	$32.97 - $56.85 $2.95 Million - $5.09 Million	89,491 New	89,491 $4.12 Million

211

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.